Combined Immunosuppression for Pediatric Crohn's Disease

PHASE4RecruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

October 10, 2022

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions
Crohn DiseaseInfliximabImmunosuppressionChildren, Only
Interventions
DRUG

Infliximab and immunosuppressives

the infusion of IFX (5mg/kg) were given at 0, 2, 6 weeks and then every 8 weeks, the immunomodulatory agent was azathioprine 1-2mg/kg per day or methotrexate 10-25 mg/m2 week

DRUG

Infliximab

the infusion of IFX (5mg/kg) were given at 0, 2, 6 weeks and then every 8 weeks

Trial Locations (1)

201102

RECRUITING

Children's Hospital of Fudan University, Shanghai

All Listed Sponsors
lead

Children's Hospital of Fudan University

OTHER